BeStock  
Markets › Compare › BALL vs ASND

BALL vs ASND

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
BALL · Ball Corp$56.24 ▲ 0.37%
ASND · Ascendis Pharma A/S$227.64 ▼ 0.08%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

89102115128141Oct 2, '25Mar 31, '26Sep 30, '26
  • BALL +12.6%
  • ASND +13.4%

Head to head

MetricBALLASND
Price$56.24$227.64
Change today▲ 0.37%▼ 0.08%
Market cap$14.89B$14.98B
Return, 3 months-8.6%-15.0%
Return, year to date+7.2%+6.8%
Return, 1 year+13.0%+18.6%
P/E (TTM)16.118.0
P/B2.69.2
P/E percentile vs own 5y21st92nd
Dividend yield1.42%–
Revenue growth (YoY, latest qtr)+19.7%+114.7%
Net profit growth (YoY)+3.7%+632.7%
Gross margin18.6%91.3%
Operating margin10.0%25.1%
Net margin6.6%70.8%
Return on equity17.3%118.8%
Analyst target vs. price+28.6%+39.5%
Analyst buy share89%100%
RSI (14)2638
30-day volatility19.2%47.9%
Max drawdown, 1 year-21.8%-19.5%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ASND is the largest of the group by market value.
  • ASND has returned the most over the past year.
  • BALL carries the lowest trailing P/E.
  • ASND is growing revenue fastest.
  • ASND keeps the most profit per dollar of sales.
  • BALL has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top